November 7, 2016
Orphan drugs make 35% Horizon's sale in Q3 2016
Horizon Pharma has announced its third-quarter 2016 financial results on Monday.
Pharmaceuticals, Biotechnology and Life Sciences
Horizon Pharma has announced its third-quarter 2016 financial results on Monday.
Horizon Pharma plc has entered a definitive agreement to acquire Crealta Holdings LLC for $510 million in cash.